Gabelli Funds’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Gabelli Funds’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-178,800	Closed	-$3.31M	–	1168
2023 Q3	$3.31M	Buy	+178,800	New	+$2.02M	0.03%	539
2022 Q4	–	Sell	-14,000	Closed	-$195K	–	1276
2022 Q3	$195K	Hold	14,000	–	–	﹤0.01%	1161
2022 Q2	$193K	Hold	14,000	–	–	﹤0.01%	1194
2022 Q1	$228K	Hold	14,000	–	–	﹤0.01%	1231
2021 Q4	$228K	Sell	14,000 -7,000	-33%	-$118K	﹤0.01%	1248
2021 Q3	$312K	Hold	21,000	–	–	﹤0.01%	1157
2021 Q2	$419K	Hold	21,000	–	–	﹤0.01%	1099
2021 Q1	$485K	Buy	+21,000	New	+$585K	﹤0.01%	1058

Gabelli Funds's ICPT Position: Q4 2023 in Review

Gabelli Funds sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 178,800 shares — an estimated $3.31M sold.

Gabelli Funds first reported a position in ICPT in Q1 2021 and held it in 8 quarters. The position peaked at $3.31M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Gabelli Funds reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Gabelli Funds sold 178,800 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $3.31M.
Gabelli Funds first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2021 and held it in 8 quarters.
Gabelli Funds's Intercept Pharmaceuticals, Inc. position peaked at $3.31M in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Gabelli Funds's 13F filing for Q4 2023, filed 13 Feb 2024.